Health Care & Life Sciences » Biotechnology | Response Genetics Inc.

Response Genetics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Cash & Short Term Investments
4,120.10
1,700.30
9,041.50
8,148.60
2,222.50
Total Accounts Receivable
4,733.70
4,047.10
5,373.00
6,225.90
7,810.40
Other Current Assets
942.00
991.40
576.10
981.90
1,182.70
Total Current Assets
9,795.80
6,738.70
14,990.60
15,356.40
11,215.70
Net Property, Plant & Equipment
805.80
1,067.70
1,023.20
1,934.60
1,406.40
Intangible Assets
-
44.40
575.40
767.20
631.10
Other Assets
-
-
-
-
191.90
Total Assets
10,601.60
7,850.80
16,589.20
18,058.20
13,445.10
ST Debt & Current Portion LT Debt
-
1,149.30
1,158.70
157.20
101.00
Accounts Payable
1,247.20
1,492.50
1,191.10
1,694.30
1,609.70
Other Current Liabilities
4,675.10
3,251.30
2,922.00
3,811.30
3,337.20
Total Current Liabilities
5,922.20
5,893.00
5,271.80
5,662.90
5,047.90
Long-Term Debt
-
240.90
11,859.60
1,136.40
9,567.30
Other Liabilities
100.10
-
-
-
-
Total Liabilities
6,022.30
6,134.00
17,131.40
6,799.30
14,615.20
Common Equity (Total)
3,275.40
6,137.80
542.20
5,759.00
1,170.10
Total Shareholders' Equity
3,275.40
6,137.80
542.20
11,259.00
1,170.10
Total Equity
3,275.40
6,137.80
542.20
11,259.00
1,170.10
Liabilities & Shareholders' Equity
10,601.60
7,850.80
16,589.20
18,058.20
13,445.10
Non-Equity Reserves
7,854.70
7,854.70
-
-
-
Preferred Stock (Carrying Value)
-
-
-
5,500.00
-

About Response Genetics

View Profile
Address
1640 Marengo Street
Los Angeles California 90033
United States
Employees -
Website http://www.responsegenetics.com
Updated 07/08/2019
Response Genetics, Inc. engages in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies.